Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation

Journal of Liposome Research

Volumn 22, Issue 2, 2012, Pages 110-119

  Lu, Yao ^a   Ding, Nan ^a   Yang, Chang ^a   Huang, Lei ^a   Liu, Jian ^a   Xiang, Guangya ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Curcumin; Folate receptor; Liposomes; Tumor targeting

Indexed keywords

CURCUMIN; FOLATE RECEPTOR; FOLIC ACID; LIPOSOME;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIPOSOMAL DELIVERY; PRIORITY JOURNAL; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CURCUMIN; DRUG SCREENING ASSAYS, ANTITUMOR; FOLIC ACID; HELA CELLS; HUMANS; KB CELLS; LIPOSOMES; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84862101385     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2011.627514     Document Type: Article

References (42)

1. Ammon, H. P., Safayhi, H., Mack, T., Sabieraj, J. (1993). Mechanism of anti-inflammatory actions of curcumin and boswellic acids. J Ethnopharmacol 38: 113-119. (Pubitemid 23136055)
2. Anand, P., Kunnumakkara, A. B., Newman, R. A., Aggarwal, B. B. (2007). Bioavailability of curcumin: problems and promises. Mol. Pharmcol 4: 807-818.
3. Anand, P., Nair, H. B., Sung, B., Kunnumakkara, A. B., Yadav, V. R., Tekmal, R. R., et al. (2010). Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increasd bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 79: 330-338.
4. Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaran, C., Harikumar, K. B., Sung, B., et al. (2008). Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochem Pharmacol 76: 1590-1611.
5. Aronov, O., Horowitz, A. T., Gabizon, A., Gibson, D. (2003). Folatetargeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies. Bioconjug Chem 14: 563-574. (Pubitemid 36597366)
6. Chattopadhyay, I., Biswas, K., Bandyopadhyay, U., Banerjee, R. K. (2004). Turmeric and curcumin: biological actions and medicinal applications. Curr Sci India 87: 44-53. (Pubitemid 39403908)
7. Chen, C. G., Johnston, T. D., Jeon, H., Gedaly, R., Burke, T. G., Ranjan, D. (2009). An in vitro study of curcumin: stability, toxicity, and biological activity in human lymphocytes and Epstin-Barr virustransformed human B-cells. Int J Pharm 366: 133-139.
8. Gabizon, A., Shmeeda, H., Horowitz, A. T., Gorit, D., Tzemach, D., Mandelbaum-Shavit, F., et al. (1999). Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug Chem 10: 289-298. (Pubitemid 29147733)
9. Gourriérec, L. L., Giorgio, C. D., Greiner, J., Vierling, P. (2008). An efficient mixed solid-liquid phase synthesis of a heterobifunctional amphiphilic PEG-NH2 derivative and its conjugation to folic acid. Tetrahedron 64: 2233-2240.
10. Hinrichs, W. L., Mancenido, F. A., Sanders, N. N., Breaeckmans, K., De Smedt, S. C., Demeester, J., et al. (2006). The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int J Pharm 311: 237-244.
11. Kim, T. H., Jiang, H. H., Youn, Y. S., Park, C. W., Tak, K. K., Lee, S., et al. (2011). Prparation and characterization of water-soluble albuminbound curcumin nanoparticles with improved antitumor activity.Int J Pharm 403: 285-291.
12. Kunwar, A., Barik, A., Pandey, R., Priyadarsini, K. I. (2006). Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochim Biophys Acta 1760: 1513-1520. (Pubitemid 44428033)
13. Leamon, C. P., Low, P. S. (2001). Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today 6: 44-51. (Pubitemid 32156966)
14. Lee, R. J., Low, P. S. (1995). Folate-mediated tumor cell targeting of liposome entrapped doxorubicin in vitro. Biochim Biophys Acta 1233: 134-144.
15. Li, L., Ahmed, B., Mehta, K., Kurzrock, R. (2007). Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 6: 1276-1282. (Pubitemid 46711990)
16. Li, L., Braiteh, F. S., Kurzrock, R. (2005). Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104: 1322-1331. (Pubitemid 41282806)
17. Low, P. S., Henne, W. A., Doorneweerd, D. D. (2008). Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory disease. Acc Chem Res 41: 120-129.
18. Low, P. S. (2004). Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Del Rev 56: 1055-1058. (Pubitemid 38496506)
19. Lu, Y. J., Low, P. S. (2002). Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Del Rev 54: 675-693 (Pubitemid 35247522)
20. Lu, Y. H., Wu, J., Lee, R. J., Wu, J. M., Gonit, M., Yang, X. J., et al. (2007). Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells. Mol Pharma 4: 707-712. (Pubitemid 350004270)
21. Maiti, K., Mukhrjee, K., Gantait, A., Saha, B. P., Mukherjee, P. K. (2007). Curcumin-phospholipid complex: preparation, theraprutic evaluation, and pharmacokinetic study in rats. Int J Pharm 330: 155-163. (Pubitemid 46097368)
22. Mohanty, C., Sahoc, S. K. (2010). The in vitro stability and in vivo pharmacokinetics of curcumin prepared as aqueous nanoparticulate formulation. Biomaterials 31: 6597-6611.
23. Narayanan, N. K., Nargi, D., Randolph, C., Narayanan, B. A. (2009). Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125: 1-8.
24. Paulos, C. M., Turk, M. J., Breur, G. J., Low, P. S. (2004). Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Del Rev 56: 1205-1217. (Pubitemid 38496516)
25. Priyadarsini, K. I. (2009). Photophysics, photochemistry, and photobiology of curcumin: studies from organic solutions, biomimetics, and living cells. J Photoch Photobio C 10: 81-95.
26. Sahu, A., Kasoju, N., Bora, U. (2008). Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules 9: 2905-2912.
27. Salmaso, S., Bersani, S., Semenzato, A., Caliceti, P. (2007). New cyclodextrin bioconjugates for active tumour targeting. J Drug Target 15: 379-390. (Pubitemid 47073053)
28. Saul, J. M., Annapragada, A., Natarajan, J. V., Bellamkonda, R. V. (2003). Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release 92: 49-67. (Pubitemid 37130121)
29. Sega, E. I., Low, P. S. (2008). Tumor detection using folate receptortargeted imaging agents. Cancer Metastasis Rev 27: 655-664.
30. Shishodia, S., Chaturvedi, M. M., Aggarwal, B. B. (2007). Role of curcumin in cancer therapy. Curr Prob Cancer 31: 243-305. (Pubitemid 47077491)
31. Sou, K., Inenaga, S., Takeoka, S., Tsuchida, E. (2008). Loading of curcumin into macrophages using lipid-based nanoparticles. Int J Pharm 352: 287-293.
32. Sudimack, J., Lee, R. J. (2000). Targeted drug delivery via the folate receptor. Adv Drug Del Rev 41: 147-162. (Pubitemid 30122955)
33. Tang, H. D., Murphy, C. J., Zhang, B., Shen, Y. Q., Kirk, E. A., Murdoch, W. J., et al. (2010). Curcumin polymers as anticancer conjugates. Biomaterials 31: 7139-7149.
34. Thamake, S. I., Raut, S. L., Ranjan, A. P., Gryczynski, Z., Vishwanatha, J. K. (2011). Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy. Nanotechnology 22: 035101.
35. Thangapazham, R. L., Puri, A., Tele, S., Blumenthal, R., Maheshwari, R. K. (2008). Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol 32: 1119-1123.
36. Wang, Y. J., Pan, M. H., Cheng, A. L., Lin, L. I., Ho, Y. S., Hsieh, C. Y., et al. (1997). Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15: 1867-1876.
37. Xiang, G. Y., Wu, J., Lee, R. J., Lu, Y. H., Liu, Z. L. (2008). Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm 356: 29-36.
38. Xiong, S. B., Yu, B., Wu, J., Li, H., Lee, R. J. (2011). Preparation, therapeutic efficacy, and intratumoral localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS. Biomed Pharmacother 65: 2-8.
39. Yallapu, M. M., Gupta, B. K., Jaggi, M., Chauhan, S. C. (2010). Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interf Sci 351: 19-29.
40. Yallapu, M. M., Maher, D. M., Sundram, V., Bell, M. C., Jaggi, M., Chauhan, S. C. (2010). Curcumin induces chemo/radiosensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res 11: 1-12.
41. Yamada, A., Taniguchi, Y., Kawano, K., Honda, T., Hattori, Y., Maitani, Y. (2008). Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Clin Cancer Res 14: 8161-8168.
42. Yoo, H. S., Park, T. G. (2004). Folate-receptor delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release 100: 247-256. (Pubitemid 39491276)